查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968051

全球動脈插管市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Arterial Cannula Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計動脈插管市場將從 2025 年的 2,970 萬美元成長到 2034 年的 5,786 萬美元，2026 年至 2034 年的複合年成長率為 7.69%。

受全球心血管手術和重症監護手術數量不斷增加的推動，全球動脈插管市場正經歷穩定成長。動脈插管是心肺體外迴圈和體外循環手術中不可或缺的醫療設備。心臟病發病率的上升和手術複雜性的增加，顯著促進了產品需求的成長。

關鍵成長要素包括微創手術技術的進步和醫療基礎設施的改善。旨在提高患者安全性和減少併發症的技術創新正在推動市場擴張。尤其值得注意的是，已開發國家人口老化加劇了對心血管手術的需求。此外，新興國家醫療服務覆蓋範圍的擴大也為製造商創造了新的機會。

展望未來，由於心臟護理技術的進步和醫療保健投資的增加，市場預計將穩定成長。生物相容性材料的開發和設計能力的提升將進一步增強產品性能。人們對早期心臟介入重要性的認知不斷提高，也將推動市場需求。鑑於心血管疾病仍然是全球主要的健康問題，動脈插管市場是一個具有長期成長潛力的領域。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球動脈插管市場：依尺寸分類

  • 市場分析、洞察與預測
  • 14-16 Fr
  • 17-19 Fr
  • 20-22 Fr
  • 23-25 Fr
  • 26-28 Fr
  • 29-31 Fr
  • 32-34 Fr
  • 35-36 Fr

第5章 全球動脈插管市場：依應用領域分類

  • 市場分析、洞察與預測
  • 心肺體外迴圈手術
  • 體外膜氧合器
  • 其他用途

第6章：全球動脈插管市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第7章 全球動脈插管市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Andocor
    • B. Braun
    • Becton Dickinson And Company
    • Edwards Lifesciences
    • Freelife Medical
    • Fresenius Medical Care
    • Getinge
    • ICU Medical
    • Kangxin Medical
    • LivaNova
    • Medtronic
    • Nipro Corporation
    • Polymedicure
    • Surgical Holdings
    • Terumo Corporation
簡介目錄
Product Code: VMR112110091

The Arterial Cannula Market size is expected to reach USD 57.86 Million in 2034 from USD 29.70 Million (2025) growing at a CAGR of 7.69% during 2026-2034.

The Global Arterial Cannula Market is experiencing steady growth, driven by increasing cardiovascular surgeries and critical care procedures worldwide. Arterial cannulas are essential medical devices used in cardiopulmonary bypass and extracorporeal circulation procedures. The rising prevalence of heart diseases and the growing number of complex surgical interventions have significantly contributed to increased product demand.

Major growth drivers include advancements in minimally invasive surgical techniques and improvements in healthcare infrastructure. Technological innovations aimed at enhancing patient safety and reducing complications are strengthening market expansion. The aging population, particularly in developed countries, is also increasing the need for cardiac procedures. Furthermore, expanding access to healthcare services in emerging economies is creating new opportunities for manufacturers.

Looking forward, the market is expected to grow steadily with the advancement of cardiac care technologies and rising healthcare investments. Development of biocompatible materials and improved design features will enhance product performance. Increasing awareness about early cardiac intervention will further support demand. As cardiovascular disease remains a leading global health concern, the Arterial Cannula Market is positioned for long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Size

  • 14-16 Fr
  • 17-19 Fr
  • 20-22 Fr
  • 23-25 Fr
  • 26-28 Fr
  • 29-31 Fr
  • 32-34 Fr
  • 35-36 Fr

By Application

  • Cardiopulmonary Bypass Surgery
  • Extracorporeal Membrane Oxygenation
  • Other Applications

By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

COMPANIES PROFILED

  • Andocor, B Braun, Becton Dickinson and Company, Edwards Lifesciences, Freelife Medical, Fresenius Medical Care, Getinge, ICU Medical, Kangxin Medical, LivaNova, Medtronic, Nipro Corporation, Polymedicure, Surgical Holdings, Terumo Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTERIAL CANNULA MARKET: BY SIZE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Size
  • 4.2. 14-16 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. 17-19 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. 20-22 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. 23-25 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. 26-28 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. 29-31 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. 32-34 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. 35-36 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTERIAL CANNULA MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Cardiopulmonary Bypass Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Extracorporeal Membrane Oxygenation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTERIAL CANNULA MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARTERIAL CANNULA MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Size
    • 7.2.2 By Application
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Size
    • 7.3.2 By Application
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Size
    • 7.4.2 By Application
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Size
    • 7.5.2 By Application
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Size
    • 7.6.2 By Application
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ARTERIAL CANNULA INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Andocor
    • 9.2.2 B. Braun
    • 9.2.3 Becton Dickinson And Company
    • 9.2.4 Edwards Lifesciences
    • 9.2.5 Freelife Medical
    • 9.2.6 Fresenius Medical Care
    • 9.2.7 Getinge
    • 9.2.8 ICU Medical
    • 9.2.9 Kangxin Medical
    • 9.2.10 LivaNova
    • 9.2.11 Medtronic
    • 9.2.12 Nipro Corporation
    • 9.2.13 Polymedicure
    • 9.2.14 Surgical Holdings
    • 9.2.15 Terumo Corporation